TCR-engineered T cells advance toward harder liver cancer targets
A 2026 review finds that TCR-engineered T cells have entered early clinical testing for hepatocellular carcinoma, but safety, antigen heterogeneity ...
A 2026 review finds that TCR-engineered T cells have entered early clinical testing for hepatocellular carcinoma, but safety, antigen heterogeneity ...
A new review outlines how gene-modified mesenchymal stem cell-derived exosomes could simultaneously repair insulin signalling, inflammation, and mitochondrial dysfunction in ...
Researchers have engineered T cell receptors fused to the co-stimulatory molecule ICOS, producing T cells that persist longer, resist exhaustion ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine